+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 115619-01-7
115619-01-7,MFCD00702246
Catalog No.:AA000G6D

115619-01-7 | 4-(4-Ethylpiperazin-1-ly)aniline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$15.00   $11.00
- +
5g
98%
in stock  
$29.00   $21.00
- +
25g
98%
in stock  
$105.00   $74.00
- +
100g
98%
in stock  
$321.00   $225.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000G6D
Chemical Name:
4-(4-Ethylpiperazin-1-ly)aniline
CAS Number:
115619-01-7
Molecular Formula:
C12H19N3
Molecular Weight:
205.2994
MDL Number:
MFCD00702246
SMILES:
CCN1CCN(CC1)c1ccc(cc1)N
Properties
Properties
 
BP:
364.4°C at 760 mmHg  
Form:
Solid  
MP:
76-78 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
179  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
1.5  

Upstream Synthesis Route

[1]JournalofMedicinalChemistry,2011,vol.54,#20,p.7066-7083

[2]BulletinoftheKoreanChemicalSociety,2015,vol.36,#7,p.1863-1873

[3]BioorganicandMedicinalChemistryLetters,2015,vol.25,#5,p.1092-1099

[4]Patent:US2004/122237,2004,A1,.Locationinpatent:Page180

[5]Patent:WO2006/420,2006,A1,.Locationinpatent:Page/Pagecolumn210

[6]Patent:WO2006/108640,2006,A1,.Locationinpatent:Page/Pagecolumn84

[7]Patent:WO2007/71752,2007,A2,.Locationinpatent:Page/Pagecolumn73

[8]Patent:WO2011/71821,2011,A1,.Locationinpatent:Page/Pagecolumn21

[9]EuropeanJournalofMedicinalChemistry,2011,vol.46,#7,p.2917-2929

[10]EuropeanJournalofMedicinalChemistry,2014,vol.75,p.43-56

[11]Patent:WO2015/117547,2015,A1,.Locationinpatent:Page/Pagecolumn16;17

[12]ArchivesofPharmacalResearch,2016,vol.39,#5,p.603-617

[13]Patent:WO2009/141386,2009,A1,.Locationinpatent:Page/Pagecolumn67

[1]EuropeanJournalofMedicinalChemistry,2011,vol.46,#7,p.2917-2929

[2]JournalofMedicinalChemistry,2011,vol.54,#20,p.7066-7083

[3]EuropeanJournalofMedicinalChemistry,2014,vol.75,p.43-56

[4]BioorganicandMedicinalChemistryLetters,2015,vol.25,#5,p.1092-1099

[5]BulletinoftheKoreanChemicalSociety,2015,vol.36,#7,p.1863-1873

[6]Patent:WO2015/117547,2015,A1,

[7]ArchivesofPharmacalResearch,2016,vol.39,#5,p.603-617

[8]Patent:WO2009/141386,2009,A1,

[1]JournalofMedicinalChemistry,2011,vol.54,#20,p.7066-7083

[2]Patent:WO2015/117547,2015,A1,

[3]Patent:WO2009/141386,2009,A1,

[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,#5,p.1092-1099

[2]BulletinoftheKoreanChemicalSociety,2015,vol.36,#7,p.1863-1873

[3]ArchivesofPharmacalResearch,2016,vol.39,#5,p.603-617

[1]EuropeanJournalofMedicinalChemistry,2011,vol.46,#7,p.2917-2929

Downstream Synthesis Route
147594-47-6    115619-01-7   
4-(4-Ethyl-piperazin-1-yl)-phenyl-(2-methyl-2H-1,2,3triazolo4,5-fquinolin-9-yl)-amine;hydrochloride 

[1]IlFarmaco,1995,vol.50,p.47-54

[1]Patent:US2004/122237,2004,A1.Locationinpatent:Page180

[1]JournalofMedicinalChemistry,2011,vol.54,p.7066-7083

[2]BulletinoftheKoreanChemicalSociety,2015,vol.36,p.1863-1873

[3]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.1092-1099

[4]Patent:US2004/122237,2004,A1.Locationinpatent:Page180

[5]Patent:WO2006/420,2006,A1.Locationinpatent:Page/Pagecolumn210

[6]Patent:WO2006/108640,2006,A1.Locationinpatent:Page/Pagecolumn84

[7]Patent:WO2007/71752,2007,A2.Locationinpatent:Page/Pagecolumn73

[8]Patent:WO2011/71821,2011,A1.Locationinpatent:Page/Pagecolumn21

[9]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.2917-2929

[10]EuropeanJournalofMedicinalChemistry,2014,vol.75,p.43-56

[11]Patent:WO2015/117547,2015,A1.Locationinpatent:Page/Pagecolumn16;17

[12]ArchivesofPharmacalResearch,2016,vol.39,p.603-617

[13]Patent:WO2009/141386,2009,A1.Locationinpatent:Page/Pagecolumn67

[14]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.690-709

[15]Patent:EP3466948,2019,A1.Locationinpatent:Paragraph0069-0071

[1]Patent:WO2017/15400,2017,A1.Locationinpatent:Paragraph0065

[2]Patent:WO2006/420,2006,A1.Locationinpatent:Page/Pagecolumn281

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 115619-01-7
1172518-57-8

1172518-57-8

 2009011-61-2

2009011-61-2

 1172518-57-8

1172518-57-8

 115619-00-6

115619-00-6

 125421-98-9

125421-98-9

 125422-03-9

125422-03-9
Building Blocks
More >
Tags:115619-01-7 Molecular Formula|115619-01-7 MDL|115619-01-7 SMILES|115619-01-7 4-(4-Ethylpiperazin-1-ly)aniline